<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Bioeng. Biotechnol.</journal-id>
<journal-title>Frontiers in Bioengineering and Biotechnology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Bioeng. Biotechnol.</abbrev-journal-title>
<issn pub-type="epub">2296-4185</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1392339</article-id>
<article-id pub-id-type="doi">10.3389/fbioe.2024.1392339</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Bioengineering and Biotechnology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Radioprotective effect of polyvinylpyrrolidone modified selenium nanoparticles and its antioxidation mechanism <italic>in vitro</italic> and <italic>in vivo</italic>
</article-title>
<alt-title alt-title-type="left-running-head">Li et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fbioe.2024.1392339">10.3389/fbioe.2024.1392339</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Wei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2021325/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lu</surname>
<given-names>Xianzhou</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jiang</surname>
<given-names>Liangjun</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wang</surname>
<given-names>Xiangjiang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2630789/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>School of Nuclear Science and Technology</institution>, <addr-line>Hengyang</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>The Affiliated Nanhua Hospital</institution>, <institution>University of South China</institution>, <addr-line>Hengyang</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Hunan Provincial Key Laboratory of Emergency Safety Operation Technology and Equipment for Nuclear Facilities</institution>, <addr-line>Hengyang</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1108088/overview">Hamed Barabadi</ext-link>, Shahid Beheshti University of Medical Sciences, Iran</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1497935/overview">Mohamed El-Missiry</ext-link>, Mansoura University, Egypt</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2675488/overview">Krishnan Nair</ext-link>, Amrita Vishwa Vidyapeetham (kochi campus), India</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Xiangjiang Wang, <email>wangxiangjiang72@163.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>19</day>
<month>06</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>12</volume>
<elocation-id>1392339</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>02</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>04</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Li, Lu, Jiang and Wang.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Li, Lu, Jiang and Wang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Objective</title>
<p>Polyvinylpyrrolidone (PVP) is a commonly used biomedical polymer material with good water solubility, biocompatibility, low immunogenicity, and low toxicity. The aim of this study is to investigate the antioxidant mechanism and clinical potential of PVP modified selenium nanoparticles (PVP-Se NPs) as a new radioprotective agent.</p>
</sec>
<sec>
<title>Methods</title>
<p>A laser particle size analyzer and transmission electron microscope were used to characterize PVP-Se nanoparticles prepared by chemical reduction. Human umbilical vein endothelial cells (HUVECs) were used to evaluate the radiation protective effects of PVP-Se NPs. SD rats were employed as an <italic>in vivo</italic> model to identify the most effective concentration of PVP-Se NPs and assess their potential radioprotective properties. Western blot (WB) was used to detect the expression of nuclear factor kappa-B (NF-&#x3ba;B) and mitogen-activated protein kinase (MAPK) signaling proteins in human umbilical vein endothelial cells (HUVECs) and rat liver and kidney tissues.</p>
</sec>
<sec>
<title>Results</title>
<p>PVP-Se NPs could reduce the oxidative stress injury and inflammatory response caused by X-ray irradiation in HUVECs and rats, and inhibit cell apoptosis by modulating NF-&#x3ba;B and MAPK signaling pathways. PVP-Se NPs could increase HUVECs viability, reduce apoptosis, inhibit inflammatory factors IL-1&#x3b2;, IL-6 and TNF-&#x3b1;, improve the survival rate of rats, promote antioxidant enzyme activities in cells and rats, reduce malondialdehyde concentration in serum, and reduce the expression of inflammatory factors such as IL-1&#x3b2;, IL-6 and TNF-&#x3b1; in cell supernatant and liver and kidney tissues. PVP-Se NPs could significantly reduce the phosphorylation levels of NF-&#x3ba;B and MAPK pathway-associated proteins in HUVECs and rat liver and kidney tissues (<italic>p</italic> &#x3c; 0.05).</p>
</sec>
<sec>
<title>Conclusion</title>
<p>PVP-Se NPs can protect against radiation-induced oxidative damage by modulating NF-kB and MAPK pathways, providing a theoretical basis and experimental data for their use as an effective radioprotective agent.</p>
</sec>
</abstract>
<kwd-group>
<kwd>antioxidation</kwd>
<kwd>polyvinylpyrrolidone modification</kwd>
<kwd>radiation protection</kwd>
<kwd>selenium nanoparticles</kwd>
<kwd>nuclear science and technology</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Nanobiotechnology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Radiation refers to the phenomenon of energy release and propagation (<xref ref-type="bibr" rid="B8">Du et al., 2023</xref>). Radiation can be categorized as either ionizing or non-ionizing. Ionizing radiation has greater energy, causing atoms or molecules in a substance to be ionized, leading to DNA damage, gene mutations, cell death, or carcinogenesis (<xref ref-type="bibr" rid="B22">Liu et al., 2023</xref>; <xref ref-type="bibr" rid="B26">Ortega et al., 2023</xref>). Radiation protection aims to take various measures to reduce or avoid the harm of radiation to human health and the environment. At present, radiation protection consists mainly of three approaches: physical protection, chemical protection, and biological protection (<xref ref-type="bibr" rid="B40">Yang et al., 2020</xref>). Among them, chemical protection is the use of specific compounds or elements to enhance organisms&#x2019; tolerance to radiation and reduce the harm caused by radiation (<xref ref-type="bibr" rid="B1">Andrady et al., 2023</xref>; <xref ref-type="bibr" rid="B14">Javadi et al., 2023</xref>).</p>
<p>Selenium (Se) plays a significant role in many physiological functions such as antioxidants, immune regulation, and thyroid hormone synthesis, as described in the report (<xref ref-type="bibr" rid="B19">Li et al., 2021a</xref>; <xref ref-type="bibr" rid="B39">Wu et al., 2021</xref>; <xref ref-type="bibr" rid="B30">Rao et al., 2022</xref>). Research has shown that Se downregulates inflammatory mediators TNF-&#x3b1;, IL-1&#x3b2; and IL-6 gene expressions via TLR2, NF-&#x3ba;B and MAPK signaling pathway in S. aureus-stimulated bMECs, which may be responsible for the anti-inflammatory effect of Se (<xref ref-type="bibr" rid="B36">Wang et al., 2018</xref>). As early as 1964, selenium compounds were discovered to have radiation protection effects. It protects organisms from radiation damage through mechanisms such as clearing free radicals, maintaining glutathione levels, and regulating signaling pathways (<xref ref-type="bibr" rid="B32">Shimazu et al., 1964</xref>). However, the bioavailability and activity of selenium are influenced by factors such as its chemical form, dosage, and distribution within the organism (<xref ref-type="bibr" rid="B29">Ragini and Arumugam, 2023</xref>). For example, In the form of organic selenium compounds, selenium exhibits radiation protection effects only at moderate concentrations, while higher concentrations are toxic to cells (<xref ref-type="bibr" rid="B29">Ragini and Arumugam, 2023</xref>). Moreover, selenium compounds demonstrate a combination of preventive (effective before exposure to ionizing radiation) and mitigating (effective after exposure to ionizing radiation, prior to the development of the first clinical signs of radiation sickness), demonstrating their multiple characteristics. Therefore, the development of efficient, safe, and stable selenium-based radiation protection agents is of critical significance.</p>
<p>Nanotechnology refers to the technology of utilizing nanoscale substances or structures to achieve novel functions or performance (<xref ref-type="bibr" rid="B9">El-Morsy et al., 2022</xref>). Nanotechnology has a wide range of potential uses in radiation protection due to its unique optical, electronic, magnetic, catalytic, and biological characteristics (<xref ref-type="bibr" rid="B27">Pan et al., 2022</xref>). For example, ZnO and TiO<sub>2</sub> nanoparticles demonstrate effectiveness in shielding against ultraviolet radiation by absorbing and blocking it, thus hindering its penetration into the tissues and cells of human (<xref ref-type="bibr" rid="B4">Cai et al., 2013</xref>; <xref ref-type="bibr" rid="B16">Khan et al., 2023</xref>). Moreover, another study has shown that CeO<sub>2</sub> nanoparticles protect gastrointestinal epithelial cells and human lymphocytes from ionizing radiation by reducing oxidative stress and inflammatory reactions (<xref ref-type="bibr" rid="B34">Tarnuzzer et al., 2005</xref>; <xref ref-type="bibr" rid="B25">Niu et al., 2007</xref>). These findings emphasize the potential of nanoparticles in safeguarding normal cells and tissues from radiation-induced harm. In recent years, nano selenium (Se NPs) has attracted much attention as a new type of selenium-based radiation protection agent. Se NPs exhibit remarkable antioxidant properties, capable of neutralizing free radicals induced by radiation, thereby reducing oxidative stress and protecting cells from damage (<xref ref-type="bibr" rid="B28">Pereira et al., 2022</xref>). Moreover, Se NPs has been reported to inhibit radiation-induced cell apoptosis, mitigating direct cellular damage caused by radiation exposure (<xref ref-type="bibr" rid="B13">Gudkov et al., 2023</xref>). Furthermore, Se NPs effectively mitigate radiation-induced inflammatory responses, thereby reducing cell death and tissue damage resulting from inflammation (<xref ref-type="bibr" rid="B41">Zahran et al., 2017</xref>). However, Se NPs also have some shortcomings, such as easy oxidation, instability, and difficulty controlling particle size (<xref ref-type="bibr" rid="B5">Carroll et al., 2020</xref>). Surface modification of Se NPs is therefore one of the most effective ways to enhance their radiation protection properties.</p>
<p>Polyvinylpyrrolidone (PVP) is a commonly used biomedical polymer material with good water solubility, biocompatibility, low immunogenicity, and low toxicity (<xref ref-type="bibr" rid="B31">Ruiz-Fresneda et al., 2023</xref>). PVP can be used as an ideal surface modifier to improve the stability, dispersibility, and bioavailability of Se NPs. Previous studies have shown that treating rats with 5 or 10&#xa0;Gy X-rays and then detecting their cardiopulmonary structure and physiological function can better describe the natural history of this injury (<xref ref-type="bibr" rid="B12">Ghosh et al., 2009</xref>). In this study, PVP-Se NPs are prepared by a chemical reduction method and tested <italic>in vitro</italic> and <italic>in vivo</italic> on human umbilical vein endothelial cells (HUVECs) and SD rats, respectively, for radiation protection. Meanwhile, Western blotting was conducted to measure the effects of PVP-Se NPs on HUVECs and MAPK-NF-&#x3ba;B pathway-related proteins in rats&#x2019; livers and kidneys, to provide novel preventive measures for radiation protection. These research results will contribute to a deeper understanding of PVP-Se NPs&#x2019; radiation protection potential.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and methods</title>
<sec id="s2-1">
<title>Materials and reagents</title>
<p>Chitosan (CTS) and ascorbic acid (Vc) were acquired from Tokyo Chemical Industry in Japan; Human umbilical vein endothelial cells (HUVECs) were obtained from the ATCC cell bank (Cat. NO.AC337632), and cells were cultured in H-DMEM (Hyclone, US) supplemented with 10% fetal bovine serum (Exocell, China), 1% antibiotics (Hyclone, US) at 37&#xb0;C with 5% CO<sub>2</sub>. Cells were passaged every 3&#xa0;days or when confluent. Fetal bovine serum (FBS), Dulbecco&#x2019;s modified Eagle&#x2019;s medium (DMEM), and SD rats from the Guangdong Provincial Experimental Animal Center were purchased from Gibco Corporation in the United States. CCK8 and Annexin-V/PI kits were acquired from Shanghai Biyuntian Biotechnology Co., Ltd.; CAT(Cat. NO. A007-1, GSH-Px (Cat. NO. A005-1, SOD (Cat. NO. A001-3), MDA (Cat. NO. A003-1) kits were acquired from Nanjing Jiancheng Biotechnology Research Institute; IL-6 (Cat. NO. EK106/2-48), IL-1&#x3b2; (Cat. NO.EK101-48), TNF-&#x3b1; (Cat. NO.EK182-48) ELISA kits were purchased from Lianchuan Biotechnology Co., Ltd.; P-I&#x3ba;B (Catalog: AF2002), I&#x3ba;B (Catalog: AF5002), NF-&#x3ba;B (Catalog: AF0874), p-p65 (Catalog: AF3389), p65 (Catalog: AF5006), p-JNK (Catalog: AF3318), JNK (Catalog: AF6318), p-ERK (Catalog: AF1015), ERK (Catalog: AF0155), p-p38 (Catalog: AF6455), and p38 (Catalog: AF6456) antibodies were acquired from Affinity Corporation. Secondary antibodies used in Western blot analysis were acquired from Abcam.</p>
</sec>
</sec>
<sec sec-type="methods" id="s3">
<title>Methods</title>
<sec id="s3-1">
<title>Preparation and characterization of PVP-Se NPs</title>
<p>Dissolve 0.5&#xa0;g of CTS and 1.6&#xa0;g of ascorbic acid (Vc) in 100&#xa0;mL of 1% (w/w) acetic acid. Incorporate 10&#xa0;mL of sodium selenite solution containing 0.4&#xa0;g/10&#xa0;mL slowly, stirring at 800&#xa0;rpm/min for at least 8&#xa0;h at room temperature. Mix the colloid with acetone solution, centrifuge at 12,000&#xa0;rpm/min for 5&#xa0;min, and discard the supernatant. Then put the nanomaterials into a dialysis bag, add deionized water for dialysis for 24&#xa0;h, change the water every 1&#xa0;h within the first 6&#xa0;h, and change the water at 12 and 18&#xa0;h respectively. Remove the nanomaterials, centrifuge at 12,000&#xa0;rpm/min for 5&#xa0;min, and remove the supernatant. Vacuum dry and weigh at 50&#xb0;C to obtain nano-selenium samples. We examined the particle size, morphology, and distribution of PVP-Se NPs utilizing a laser particle size analyzer (DLS) and transmission electron microscopy (TEM).</p>
</sec>
<sec id="s3-2">
<title>
<italic>In vitro</italic> biological evaluation of PVP-Se NPs</title>
<sec id="s3-2-1">
<title>Screening of the optimal concentration and X-ray dose of PVP-Se NPs</title>
<p>Inoculate HUVECs onto a 96-well plate and divide them into a control and experimental group. For the control group, cells were treated with 0, 18, 36, and 72&#xa0;&#x3bc;g/mL PVP-Se NPs respectively for 24&#xa0;h, followed by no X-ray treatment. The experimental group was split into eight subgroups: Cells were treated with 0, 18, 36, and 72&#xa0;&#x3bc;g/mL PVP-Se NPs for 24&#xa0;h and then subjected to radiation treatment using X-ray doses of 5&#xa0;Gy and 10&#xa0;Gy, respectively. Then add 10&#xa0;&#x3bc;L CCK-8 reaction solution to each hole. Incubate for 2&#xa0;h, and measure the absorbance at 450&#xa0;nm using an enzyme-linked immunosorbent assay.</p>
</sec>
<sec id="s3-2-2">
<title>Flow cytometry</title>
<p>Flow cytometry (ThermoFisher Attune NxT, United States) is used to detect cell apoptosis. Set up a control group and an experimental group according to the optimal concentration and X-ray dose selected above. Inoculated HUVEC cells were cultured overnight in a 6-well plate. As a control group, PVP-Se NPs were administered at a concentration of 0&#xa0;g/mL, and as an experimental group, PVP-Se NPs were utilized. After 24&#xa0;h, all cells were subjected to X-ray irradiation. Each group&#x2019;s cells were collected and washed twice with PBS after 48&#xa0;h. Apoptosis was detected immediately after 15&#xa0;min of double staining with Annexin V-FITC and PI.</p>
</sec>
<sec id="s3-2-3">
<title>Detection of cellular oxidative stress levels</title>
<p>The methodology employed for the grouping treatment followed the same protocol as described in &#x201c;<italic>Detection of cell apoptosis level</italic>&#x201d;. Subsequently, the concentrations of catalase (CAT), glutathione peroxidase (GSH-Px), superoxide dismutase (SOD), and malondialdehyde (MDA) in the cellular supernatant were quantified using a specialized reagent kit.</p>
</sec>
<sec id="s3-2-4">
<title>Detection of cellular inflammatory factor content</title>
<p>This treatment is the same as &#x201c;<italic>Detection of cell apoptosis level</italic>,&#x201d; using an ELISA kit and following the instructions to determine the absorbance (OD) value at 450&#xa0;nm using an enzyme-linked immunosorbent assay (ELISA). In the end, the levels of interleukin-1 &#x3b2; (IL-1&#x3b2;), tumor necrosis factor- &#x3b1; (TNF-&#x3b1;) and interleukin-6 (IL-6) in the supernatant of each cell group were determined according to a standard curve.</p>
</sec>
<sec id="s3-2-5">
<title>Western blot analysis</title>
<p>Proteins from each group of cells, the liver and kidney tissues of rats are extracted and quantified using the BCA method. They are separated by SDS-PAGE electrophoresis, and membranes are transferred. After blocking for hours, they were incubated with the primary antibody at 4&#xb0;C overnight and the secondary antibody at room temperature for 1&#xa0;h. Finally, chemiluminescence development was carried out.</p>
</sec>
</sec>
<sec id="s3-3">
<title>
<italic>In vivo</italic> efficacy evaluation of PVP-Se NPs</title>
<sec id="s3-3-1">
<title>Screening of the optimal concentration of PVP-Se NPs for radiation protection in rats</title>
<p>A total of 32 6&#x2013;8&#xa0;weeks SD rats were randomly divided into four groups, each containing eight rats. Whole-body 10&#xa0;Gy (2&#xa0;Gy/min) X-ray irradiation was performed following intraperitoneal injection of 200&#xa0;&#x3bc;L of PVP-Se NPs at concentrations of 0, 18, 36, and 72&#xa0;&#x3bc;g/mL. Once the rats had been irradiated, they were placed in a clean box and returned to the barrier laboratory for cage feeding. Throughout the 15-day period, the number of survivors was counted regularly, and the survival rate was calculated. The optimal concentration of PVP-Se NPs was selected. This study is approved by the Ethics Committee of the Affiliated Nanhua Hospital, University of South China (NO. 2022-ky-21). All animal studies were conducted in accordance with animal care standards, and all experiments were conducted in accordance with the guidelines of the institutional animal ethics committee.</p>
</sec>
<sec id="s3-3-2">
<title>HE staining and IHC</title>
<p>At the optimal concentration selected in &#x201c;<italic>In vivo</italic> efficacy evaluation of PVP-Se NPs,&#x201d; we set up a control group and an experimental group respectively. On the 15th day after radiation, the rats were euthanized by the cervical dislocation method, and the liver and kidney tissues were quickly removed. They were fixed in 4% formaldehyde for 24&#xa0;h, and paraffin sections were routinely prepared. An optical microscope was used to observe and photograph them following HE staining.</p>
<p>For IHC, sections of the liver and kidney tissues were treated with xylene and graded alcohol and then subjected to antigen retrieval in 0.01&#xa0;M citrate buffer. Hydrogen peroxide was used for blockage. The sections were incubated with goat serum for 30&#xa0;min and then with anti-IL-1&#x3b2;, anti-IL-6 and anti-TNF-&#x3b1; antibodies overnight at 4&#xb0;C. Subsequently, slides were incubated with biotin-linked secondary antibody and peroxidase-labelled streptavidin followed by a diaminobenzidine (substrate of peroxidase) revelation and counterstaining with Mayer&#x2019;s hematoxylin. Slices were analyzed under a microscope.</p>
</sec>
<sec id="s3-3-3">
<title>Detection of oxidative stress levels</title>
<p>Grouping processing is the same as &#x201c;<italic>HE staining and IHC</italic>&#x201d;. The control group received intraperitoneal injection of 200&#xa0;&#xb5;L PVP-Se NPs without X-ray irradiation; The experimental group was intraperitoneally injected with 200&#xa0;&#xb5;L of PVP-Se NPs and subjected to whole-body 10&#xa0;Gy (2&#xa0;Gy/min) X-ray irradiation. Collect serum from rats for 15&#xa0;days and detect the expression level of oxidative stress.</p>
</sec>
<sec id="s3-3-4">
<title>TUNEL staining</title>
<p>The grouping treatment is the same as that described in &#x201c;<italic>HE staining</italic>.&#x201d; TUNEL staining was performed after 15&#xa0;days in order to identify inflammatory factors in the liver and kidneys of the rats. The stained slices were microscopically magnified (&#xd7;400, Axiovert 25C; Carl Zeiss, Germany) and colored photomicrographs were taken using a digital camera (Canon Eos 1000D, Japan). Pictures were standardized (&#x201c;autocontrast&#x201d; function, Adobe Photoshop CS5 Extended, United States) and the number of TUNEL-positive cells was counted in particular grids within VCN (0.22&#xa0;mm &#xd7; 0.17&#xa0;mm), the fusiform layer of DCN (0.16&#xa0;mm &#xd7; 0.1&#xa0;mm), and the ICC (0.45&#xa0;mm &#xd7; 0.33&#xa0;mm).</p>
</sec>
</sec>
<sec id="s3-4">
<title>Statistical analysis</title>
<p>Statistical analysis was performed using SPSS 22.0, and measurement was defined as mean &#xb1; SD. The groups were compared by using one-way ANOVA and Dunnett&#x2019;s test. Statistics are significant when they have <italic>p</italic> &#x3c; 0.05.</p>
</sec>
</sec>
<sec sec-type="results" id="s4">
<title>Results</title>
<sec id="s4-1">
<title>Physicochemical properties of PVP-Se NPs</title>
<p>The average particle size of PVP-Se NPs observed by a laser particle size analyzer was 278.4&#xa0;nm (<xref ref-type="fig" rid="F1">Figure 1A</xref>). Through transmission electron microscopy, it was observed that PVP-Se NPs were hemispherical in shape, with a smooth surface and no obvious aggregation phenomenon (<xref ref-type="fig" rid="F1">Figure 1B</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Physicochemical properties of PVP Se NPs <bold>(A)</bold>. The particle size distribution of PVP Se NPs; <bold>(B)</bold>. Transmission Electron Microscopic Observation of PVP-Se NPs.</p>
</caption>
<graphic xlink:href="fbioe-12-1392339-g001.tif"/>
</fig>
</sec>
<sec id="s4-2">
<title>Effects of PVP-Se NPs and X-rays on the viability of HUVECs cells</title>
<p>To determine the optimal level of PVP-Se NPs and the optimal dose of X-rays, the CCK-8 experiment was conducted. The results showed (<xref ref-type="fig" rid="F2">Figure 2</xref>) that in the absence of radiation treatment, the activity of HUVECs cells decreased as the concentration of PVP-Se NPs increased; After radiation treatment, PVP-Se NPs can significantly increase the cell viability of HUVECs, and with the increase of PVP-Se NPs concentration, the cell viability increases (<italic>p</italic> &#x3c; 0.01). At two X-ray doses of 5&#xa0;Gy and 10&#xa0;Gy, 36&#xa0;&#x3bc;g/mL PVP-Se NPs showed the best protective effect, and at the same concentration, the cell activity of 10&#xa0;Gy was higher than that of 5&#xa0;Gy. Therefore, choose 36&#xa0;&#x3bc;g/mL concentration and 10&#xa0;Gy dose for subsequent experiments.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Effects of different concentrations of PVP-Se NPs and doses of X-rays on the viability of HUVECs cells Data are expressed as mean &#x2b;standard deviation (<italic>n</italic> &#x3d; 6), &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01.</p>
</caption>
<graphic xlink:href="fbioe-12-1392339-g002.tif"/>
</fig>
</sec>
<sec id="s4-3">
<title>PVP-Se NPs resist HUVECs cell apoptosis <italic>in vitro</italic>
</title>
<p>It was found that treated cells with 36&#xa0;g/mL PVP-Se NPs displayed a lower apoptosis rate than control cells; however, the difference was not statistically significant (<xref ref-type="fig" rid="F3">Figure 3</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>PVP Se NPs inhibit HUVECs cell apoptosis <bold>(A)</bold>. The apoptosis rate was detected using Annexin V-FITC/PI double staining method; <bold>(B)</bold>. Statistical analysis of cell apoptosis rate.</p>
</caption>
<graphic xlink:href="fbioe-12-1392339-g003.tif"/>
</fig>
</sec>
<sec id="s4-4">
<title>PVP Se NPs inhibit oxidative stress damage and inflammatory factor levels in HUVECs cells</title>
<p>The levels of oxidative stress factors and inflammatory factors were assessed using an ELISA kit. The findings depicted in <xref ref-type="fig" rid="F4">Figure 4</xref> indicated that the PVP-Se NPs group exhibited a notable decrease in MDA, IL-6, IL-1&#x3b2;, and TNF-&#x3b1; content, when compared to the control group. Conversely, the levels of CAT, GSH-Px, and SOD were significantly elevated in the PVP-Se NPs group (<italic>p</italic> &#x3c; 0.05). This indicates that PVP Se NPs can alleviate radiation-induced oxidative stress and inflammation.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Effect of PVP-Se NPs on oxidative stress damage and inflammatory factor secretion in HUVECs cells <bold>(A)</bold>. MDA content; <bold>(B)</bold> CAT content; <bold>(C)</bold>. GSH-Px content; <bold>(D)</bold>. SOD content; <bold>(E)</bold>. IL-6 content; <bold>(F)</bold>. IL-1&#x3b2; content; <bold>(G)</bold>. TNF- &#x3b1; content. The data is represented as mean &#xb1; standard deviation (<italic>n</italic> &#x3d; 3), &#x2a;<italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01.</p>
</caption>
<graphic xlink:href="fbioe-12-1392339-g004.tif"/>
</fig>
</sec>
<sec id="s4-5">
<title>PVP-Se NPs inhibit the expression of HUVECs cell related proteins</title>
<p>The expression levels of proteins related to the NF-&#x3ba;B and MAPK signaling pathways were determined by Western blot analysis. The results indicated that in comparison with the control group, PVP Se NPs significantly inhibited the activity of p-I&#x3ba;B-&#x3b1;, p-p65 in the NF-&#x3ba;B pathway, and inhibited the activity of p-JNK, p-ERK, and p-p38 in the MAPK signaling pathway (<italic>p</italic> &#x3c; 0.05), thereby exerting a radiation protective effect (<xref ref-type="fig" rid="F5">Figure 5</xref>).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Western blot was performed to detect NF-&#x3ba;B and MAPK-associated proteins in HUVECs.</p>
</caption>
<graphic xlink:href="fbioe-12-1392339-g005.tif"/>
</fig>
</sec>
<sec id="s4-6">
<title>Screening of the optimal concentration of PVP-Se NPs <italic>in vivo</italic> and improvement of radiation damage in rats.</title>
<p>Without radiation treatment, 0, 18, and 36&#xa0;&#x3bc;g/mL of PVP Se NPs did not significantly affect the survival rate of rats, 72&#xa0;&#x3bc;g/mL of PVP Se NPs inhibits rat survival, indicating 36&#xa0;&#x3bc;g/mL PVP Se NPs is relatively safe for rats, so this concentration was selected for subsequent experiments (<xref ref-type="fig" rid="F6">Figure 6A</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Screening of the optimal concentration of PVP-Se NPs for radiation protection in rats <bold>(A)</bold> 15 days survival rate of rats; <bold>(B)</bold>. HE staining observation of pathological changes in liver and kidney tissues (400 &#xd7;).</p>
</caption>
<graphic xlink:href="fbioe-12-1392339-g006.tif"/>
</fig>
<p>HE staining shows (<xref ref-type="fig" rid="F6">Figure 6B</xref>) diffuse mild vacuolar degeneration of liver cells in the control group (blue arrow). Mild mononuclear inflammatory cell infiltration can be seen around the central vein and portal vessels (black arrow). No vascular or bile duct hyperplasia was observed in the portal area; In the PVP-Se NPs treated group, the liver cell cords were arranged neatly, and the hepatic sinuses were clearly visible. Interlobular arteries, veins, and interlobular bile ducts in the portal area do not exhibit dilation or proliferation; no inflammatory cells are infiltrated, and fibrous tissue does not proliferate. The control group showed multifocal mild mononuclear inflammatory cell infiltration in the urinary tubulointerstitium (black arrow). Mild fibrous tissue hyperplasia around blood vessels (blue arrow); In the PVP-Se NPs treated group, there was no edema or degeneration of renal tubular epithelial cells, and no exudate or tubular type was found in the lumen. Interstitial blood vessels in the kidney did not dilate or become inflamed with inflammatory cells.</p>
</sec>
<sec id="s4-7">
<title>PVP-Se NPs improve radiation-induced oxidative stress damage in rats</title>
<p>Based on the study results (<xref ref-type="fig" rid="F7">Figure 7</xref>), the PVP-Se NPs group&#x2019;s MDA content was significantly lower than the control group&#x2019;s (<italic>p</italic> &#x3c; 0.05), whereas levels of CAT, GSH-Px, and SOD were significantly higher (<italic>p</italic> &#x3c; 0.01). This indicates that PVP Se NPs can reduce radiation-induced oxidative stress.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Antioxidant stress effect of PVP-Se NPs in rats <bold>(A)</bold>. MDA content; <bold>(B)</bold>. CAT activity; <bold>(C)</bold>. GSH-Px activity; <bold>(D)</bold>. SOD activity. Mean and standard deviation are used to represent the data (<italic>n</italic> &#x3d; 4), &#x2a;<italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01.</p>
</caption>
<graphic xlink:href="fbioe-12-1392339-g007.tif"/>
</fig>
</sec>
<sec id="s4-8">
<title>PVP-Se NPs inhibit radiation-induced cell apoptosis in rats</title>
<p>The TUNEL staining results (<xref ref-type="fig" rid="F8">Figure 8</xref>) indicated that compared to the control group, cells treated with PVP-Se NPs had a lower apoptosis rate, indicating that PVP-Se NPs significantly inhibited radiation-induced apoptosis in rats&#x2019; liver and kidney tissues (<italic>p</italic> &#x3c; 0.01).</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>Inhibition of cell apoptosis by PVP Se NPs in rats&#x2019; liver and kidney tissues <bold>(A)</bold>. TUNEL staining observation of cell apoptosis in rats&#x2019; liver and kidney (400 &#xd7;); <bold>(B)</bold>. Statistical analysis of the apoptosis rate in rat liver tissue cells; <bold>(C)</bold>. Analysis of the apoptosis rate in rat kidney tissue cells. Data are presented as mean and standard deviation (<italic>n</italic> &#x3d; 3), <italic>p</italic> &#x3c; 0.05, &#x2a;<italic>p</italic> &#x3c; 0.01.</p>
</caption>
<graphic xlink:href="fbioe-12-1392339-g008.tif"/>
</fig>
</sec>
<sec id="s4-9">
<title>PVP-Se NPs inhibit radiation induced inflammatory factor expression in rats</title>
<p>The expression of inflammatory factor IL-1&#x3b2;, IL-6 and TNF-&#x3b1; in rats&#x2019; liver and kidney tissues was determined by immunohistochemistry, as illustrated in the figure (<xref ref-type="fig" rid="F9">Figure 9</xref>). Both the control group and PVP-Se NPs group showed positive expression of diffuse hepatocyte cytoplasmic IL-1&#x3b2;, but the positive area of liver cells in the control group was slightly higher than that in the PVP-Se NPs group. The majority of renal collecting ducts and some distal convoluted tubules in the kidney control group and PVP-Se NPs group showed IL-1&#x3b2; positivity, but the levels of positivity in the control group were higher than those in the PVP-Se NPs group. No IL-1&#x3b2; positive reaction was observed in the liver of the control group and PVP-Se NPs group; All kidneys showed IL-6 positive reaction in the collecting duct, and there was no difference in the positive area and staining degree. One case of Kupffer cell TNF-&#x3b1; positive was found in the liver control group, while no positive reaction was found in all other liver samples; One case in the PVP-Se NPs group showed no TNF-&#x3b1; positive reaction in the kidneys, while all other submitted kidneys revealed TNF-&#x3b1; positive reaction in the collecting duct. There was no difference in the positive area and staining degree.</p>
<fig id="F9" position="float">
<label>FIGURE 9</label>
<caption>
<p>Immunohistochemical detection of inflammatory factors in the rat liver and kidney (40&#xd7;). The blue arrow shows a positive staining of brownish yellow.</p>
</caption>
<graphic xlink:href="fbioe-12-1392339-g009.tif"/>
</fig>
</sec>
<sec id="s4-10">
<title>PVP-Se NPs inhibit the expression of oxidative related proteins in rats</title>
<p>Western blots were used to analyze NF-&#x3ba;B and MAPK pathway-related proteins in rat liver and kidney tissues. It was found that compared to the control group, PVP-Se NPs significantly inhibited p-I&#x3ba;B-&#x3b1; and p-p65 in the NF-&#x3ba;B signaling pathway (<italic>p</italic> &#x3c; 0.01). The presence of p-p65 significantly inhibits the expression of p-JNK, p-ERK, and p-p38 in the MAPK regulatory pathway (<italic>p</italic> &#x3c; 0.05), thereby exerting antioxidant and radiation protective effects (<xref ref-type="fig" rid="F10">Figure 10</xref>).</p>
<fig id="F10" position="float">
<label>FIGURE 10</label>
<caption>
<p>Western blot was used to detect NF-&#x3ba;B and MAPK pathway-related proteins in rats&#x2019; liver and kidney tissues.</p>
</caption>
<graphic xlink:href="fbioe-12-1392339-g010.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s5">
<title>Discussion</title>
<p>Finding substances to prevent radiation damage remains one of the urgent focuses in radiation biology. Although the radiation resistance effects of a large number of compounds have been studied (<xref ref-type="bibr" rid="B2">Aygun et al., 2020</xref>; <xref ref-type="bibr" rid="B17">Kreusch and Duarte, 2021</xref>; <xref ref-type="bibr" rid="B37">Wang et al., 2023</xref>), Existing radiation protection methods still fail to fully meet the requirements, especially in terms of key characteristics such as efficiency, action time, flexibility, and usability (<xref ref-type="bibr" rid="B15">Kapustka, 2022</xref>). Due to selenium&#x2019;s antioxidant properties, there is growing research focusing on its utilization in radiation protection. There are many similarities between selenium&#x2019;s chemical properties and those of sulfur. Nevertheless, some selenium derivatives exhibit a significantly higher ability to scavenge free radicals and peroxides than similar sulfur compounds. Numerous studies have demonstrated Selenium&#x2019;s antioxidant and protective properties. Selenium compounds protect biological molecules from oxidative stress (<xref ref-type="bibr" rid="B21">Li et al., 2023</xref>; <xref ref-type="bibr" rid="B23">Mamgain et al., 2023</xref>). However, conventional Se supplements present a range of challenges, including low absorption efficiency and elevated toxicity levels. Therefore, developing innovative systems as carriers of selenium compounds to improve selenium bioavailability and achieve controlled release <italic>in vivo</italic> is of significant significance.</p>
<p>Recent research has revealed that nano-modified inorganic compounds display antioxidant properties (<xref ref-type="bibr" rid="B18">Krishnan Nair et al., 2023</xref>). When utilized as therapeutic agents within the body, Se NPs can gradually release biologically available selenium in a controlled manner (<xref ref-type="bibr" rid="B42">Zhang et al., 2001</xref>). Compared to molecular forms of selenium, the toxicity of Se NPs is reduced by 50&#x2013;100 times (<xref ref-type="bibr" rid="B11">Gao et al., 2023</xref>). In this study, we synthesized polyvinylpyrrolidone-modified selenium nanoparticles (PVP Se NPs) and explored their protective effects against radiation, along with their potential molecular mechanism. Previous research has suggested that even minimal concentrations of molecular selenium could pose damage to cells (<xref ref-type="bibr" rid="B24">Maynar et al., 2018</xref>). Hence, initial screening for the optimal PVP-Se NPs concentration becomes necessary. Experimental findings reveal that the optimal concentration of PVP-Se NPs for both <italic>in vitro</italic> and <italic>in vivo</italic> is 36&#xa0;&#x3bc;g/mL.</p>
<p>It has reported that ionizing radiation can interact with cellular molecules, triggering an overproduction of free radicals and reactive oxygen species such as hydroxyl radicals, hydrogen peroxide, and superoxide radicals. This cascade of free radicals and reactive oxygen species induces oxidative stress (<xref ref-type="bibr" rid="B33">Shirazi et al., 2011</xref>). Oxidative stress damages biomacromolecules, disrupting cellular redox balance and impairing normal cellular function and homeostasis, ultimately culminating in cell death (<xref ref-type="bibr" rid="B6">Clavo et al., 2019</xref>). Additionally, ionizing radiation also has the ability to prompt the excessive release of inflammatory factors and activation of inflammatory signaling pathways (<xref ref-type="bibr" rid="B3">Baselet et al., 2019</xref>; <xref ref-type="bibr" rid="B38">Wijerathne et al., 2021</xref>). In this study, we found that PVP Se NPs significantly reduced the generation of MDA, IL-1, IL-6 and TNF-&#x3b1; increased the generation of GSH, SOD, CAT, and effectively alleviated cell apoptosis in HUVECs and rats. These findings collectively suggest that PVP Se NPs mitigate radiation-induced damage both <italic>in vitro</italic> and <italic>in vivo</italic> by alleviating oxidative stress, inflammatory responses, and cell apoptosis.</p>
<p>To further investigate the potential molecular mechanisms underlying the mitigation of radiation damage by PVP-Se NPs, we utilized Western blot analysis to assess the expression of proteins associated with the NF-&#x3ba;B and MAPK signaling pathways in HUVECs and rats. NF-&#x3ba;B serves as a pivotal nuclear transcription factor implicated in regulating various cellular processes, including proliferation, immunity, and inflammatory responses (<xref ref-type="bibr" rid="B35">Thakur and Ray, 2017</xref>). A prior study demonstrated that curcumin mitigates oxidative stress and inflammatory responses in rats by suppressing NF-&#x3ba;B signaling pathway activation, thus ameliorating radiation-induced liver damage (<xref ref-type="bibr" rid="B20">Li et al., 2021b</xref>). MAPK functions as a serine/threonine-specific protein kinase involved in regulating essential physiological and pathological cellular processes, including growth, differentiation, apoptosis, and inflammatory responses (<xref ref-type="bibr" rid="B10">Fecher et al., 2008</xref>). <xref ref-type="bibr" rid="B7">Ding et al., 2021</xref> observed decreased Mast1 expression in gastric tissue irradiated mice. Through genetic manipulation experiments, they revealed that Mast1 upregulation inhibits p38 MAPK signaling pathway activation, thereby alleviating radiation-induced gastric damage in mice. Our experimental results reveal that PVP-Se NPs decreased the expression of p-I&#x3ba;B-&#x3b1; and p-p65 in the NF-&#x3ba;B signaling pathway, as well as p-JNK, p-ERK, and p-p38 in the MAPK signaling pathway. Consequently, we hypothesize that PVP-Se NPs might be involved in radiation protection by reducing oxidative stress and inflammatory factors by inhibiting NF-&#x3ba;B and MAPK pathways.</p>
</sec>
<sec sec-type="conclusion" id="s6">
<title>Conclusion</title>
<p>In summary, PVP-Se NPs can resist X-ray induced HUVECs cell damage and rat radiation damage, and have radiation protective effects both <italic>in vivo</italic> and <italic>in vitro</italic>. The mechanism may be related to reducing oxidative stress, inhibiting inflammatory factor expression, and regulating NF-&#x3ba;B and MAPK signaling pathway gene expression. We believe that future research should prioritize several key areas. Firstly, there is a need to optimize the synthesis methods of nanomaterials to enhance the stability and biocompatibility of PVP-Se NPs <italic>in vivo</italic>, while also minimizing potential toxicity and side effects. Secondly, clinical trials should be conducted to assess the radiation protection efficacy of PVP-Se NPs in humans. Thirdly, exploration of the potential application of PVP-Se NPs in protecting against radiation contamination could help safeguard both humans and ecosystems from radiation hazards. However, it&#x27;s important to acknowledge the limitations of this study. Firstly, the investigation of the radiation protective effects of PVP-Se NPs <italic>in vitro</italic> was limited to only 1&#xa0;cell line (HUVECs). Secondly, the evaluation of PVP-Se NPs&#x2019; radiation protection effects <italic>in vivo</italic> was restricted to the liver and kidney of rats. Thirdly, the analysis was focused solely on the expression of NF-&#x3ba;B and MAPK signaling pathway-related proteins in HUVECs and rats, with no rescued experiments conducted.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s7">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/Supplementary material, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s8">
<title>Ethics statement</title>
<p>The studies involving humans were approved by the Affiliated Nanhua Hospital, University of South China. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s9">
<title>Author contributions</title>
<p>WL: Writing&#x2013;review and editing, Writing&#x2013;original draft. XL: Writing&#x2013;review and editing, Data curation. LJ: Writing&#x2013;review and editing, Formal Analysis. XW: Writing&#x2013;review and editing, Resources.</p>
</sec>
<sec sec-type="funding-information" id="s10">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This study is funded by the Key Project of Hunan Provincial Department of Education for 2023 (Project No: 23A0348), the Key Project of Hunan Provincial Health and Family Planning Commission (Project No: A2017012), and the Key Field R&#x26;D Project of Hunan Provincial Department of Science and Technology (Project No: 2020SKC 2009).</p>
</sec>
<sec sec-type="COI-statement" id="s11">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s12">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andrady</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Heikkila</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Pandey</surname>
<given-names>K. K.</given-names>
</name>
<name>
<surname>Bruckman</surname>
<given-names>L. S.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Effects of UV radiation on natural and synthetic materials</article-title>. <source>Photochem Photobiol. Sci.</source> <volume>22</volume>, <fpage>1177</fpage>&#x2013;<lpage>1202</lpage>. <pub-id pub-id-type="doi">10.1007/s43630-023-00377-6</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aygun</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Alaylar</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Turhan</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>&#x15e;akar</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Karaday&#x131;</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Al-Sayyed</surname>
<given-names>M. I. A.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Investigation of neutron and gamma radiation protective characteristics of synthesized quinoline derivatives</article-title>. <source>Int. J. Radiat. Biol.</source> <volume>96</volume>, <fpage>1423</fpage>&#x2013;<lpage>1434</lpage>. <pub-id pub-id-type="doi">10.1080/09553002.2020.1811421</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baselet</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sonveaux</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Baatout</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Aerts</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Pathological effects of ionizing radiation: endothelial activation and dysfunction</article-title>. <source>Cell. Mol. Life Sci.</source> <volume>76</volume> (<issue>4</issue>), <fpage>699</fpage>&#x2013;<lpage>728</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-018-2956-z</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Str&#xf8;mme</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Welch</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Photocatalytic antibacterial effects are maintained on resin-based TiO2 nanocomposites after cessation of UV irradiation</article-title>. <source>PLoS One</source> <volume>8</volume> (<issue>10</issue>), <fpage>e75929</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0075929</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carroll</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gardiner</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ignasiak</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Holmehave</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shimodaira</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Breitenbach</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Interaction kinetics of selenium-containing compounds with oxidants</article-title>. <source>Free Radic. Biol. Med.</source> <volume>155</volume>, <fpage>58</fpage>&#x2013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2020.05.007</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clavo</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Rodr&#xed;guez-Esparrag&#xf3;n</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Rodr&#xed;guez-Abreu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mart&#xed;nez-S&#xe1;nchez</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Llontop</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Aguiar-Bujanda</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Modulation of oxidative stress by ozone therapy in the prevention and treatment of chemotherapy-induced toxicity: review and prospects</article-title>. <source>Antioxidants (Basel)</source> <volume>8</volume> (<issue>12</issue>), <fpage>588</fpage>. <pub-id pub-id-type="doi">10.3390/antiox8120588</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Mast1 mediates radiation-induced gastric injury via the P38 MAPK pathway</article-title>. <source>Exp. Cell. Res.</source> <volume>409</volume> (<issue>2</issue>), <fpage>112913</fpage>. <pub-id pub-id-type="doi">10.1016/j.yexcr.2021.112913</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>Y. N.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X. Y.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>[Research progress of irradiation injuries anti-agents]. Zhonghua Lao dong wei sheng zhi ye</article-title>. <source>Bing Za Zhi</source> <volume>41</volume>, <fpage>237</fpage>&#x2013;<lpage>240</lpage>. <pub-id pub-id-type="doi">10.3760/cma.j.cn121094-20210813-00396</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Morsy</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Mohamed</surname>
<given-names>E. S.</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>E. A.</given-names>
</name>
<name>
<surname>Awwad</surname>
<given-names>N. S.</given-names>
</name>
<name>
<surname>Ibrahium</surname>
<given-names>H. A.</given-names>
</name>
<name>
<surname>Menazea</surname>
<given-names>A. A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Investigation on optical properties and electrical conductivity behavior of Chitosan/PVP/Se NPs NPs composite produced via one-potential laser ablation for optoelectronic applications</article-title>. <source>Opt. Quantum Electron.</source> <volume>54</volume>, <fpage>661</fpage>. <pub-id pub-id-type="doi">10.1007/s11082-022-03977-1</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fecher</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Amaravadi</surname>
<given-names>R. K.</given-names>
</name>
<name>
<surname>Flaherty</surname>
<given-names>K. T.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>The MAPK pathway in melanoma</article-title>. <source>Curr. Opin. Oncol.</source> <volume>20</volume> (<issue>2</issue>), <fpage>183</fpage>&#x2013;<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1097/cco.0b013e3282f5271c</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z. H.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Research advances in preparation, stability, application, and possible risks of nanoselenium: focus on food and food-related fields</article-title>. <source>J. Agric. Food Chem.</source> <volume>71</volume> (<issue>23</issue>), <fpage>8731</fpage>&#x2013;<lpage>8745</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jafc.3c02714</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghosh</surname>
<given-names>S. N.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>M&#xe4;der</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fish</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Moulder</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jacobs</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Vascular injury after whole thoracic x-ray irradiation in the rat</article-title>. <source>Int. J. Radiat. Oncol. Biol. Phys.</source> <volume>74</volume> (<issue>1</issue>), <fpage>192</fpage>&#x2013;<lpage>199</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijrobp.2009.01.006</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gudkov</surname>
<given-names>S. V.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Simakin</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Baryshev</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Pobedonostsev</surname>
<given-names>R. V.</given-names>
</name>
<name>
<surname>Baimler</surname>
<given-names>I. V.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Laser ablation-generated crystalline selenium nanoparticles prevent damage of DNA and proteins induced by reactive oxygen species and protect mice against injuries caused by radiation-induced oxidative stress</article-title>. <source>Mater. (Basel)</source> <volume>16</volume> (<issue>14</issue>), <fpage>5164</fpage>. <pub-id pub-id-type="doi">10.3390/ma16145164</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Javadi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nikhbakht</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Ghasemian</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Rustamzadeh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mohammadi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shirazinejad</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>
<italic>In vivo</italic> and <italic>in vitro</italic> assessments of the radioprotective potential natural and chemical compounds: a review</article-title>. <source>Int. J. Radiat. Biol.</source> <volume>99</volume>, <fpage>155</fpage>&#x2013;<lpage>165</lpage>. <pub-id pub-id-type="doi">10.1080/09553002.2022.2078007</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kapustka</surname>
<given-names>L. A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>What makes radiation protection so challenging?</article-title> <source>Int. J. Radiat. Biol.</source> <volume>98</volume>, <fpage>1008</fpage>&#x2013;<lpage>1011</lpage>. <pub-id pub-id-type="doi">10.1080/09553002.2020.1793026</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname>
<given-names>M. Z.</given-names>
</name>
<name>
<surname>Taghavian</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Fijalkowski</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Militky</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tomkova</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Venkataraman</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Effect of microwave power on bactericidal and UV protection properties of the ZnO nanorods grown cotton fabrics</article-title>. <source>Colloids Surfaces A Physicochem. Eng. Aspects</source> <volume>664</volume>, <fpage>131135</fpage>. <pub-id pub-id-type="doi">10.1016/j.colsurfa.2023.131135</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kreusch</surname>
<given-names>M. G.</given-names>
</name>
<name>
<surname>Duarte</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Photoprotective compounds and radioresistance in pigmented and non-pigmented yeasts</article-title>. <source>Appl. Microbiol. Biotechnol.</source> <volume>105</volume>, <fpage>3521</fpage>&#x2013;<lpage>3532</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-021-11271-5</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krishnan Nair</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Menon</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chandrasekharan</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>The importance of nanoparticles for development of radioprotective agents</article-title>. <source>Int. J. Radiol. Radiat. Ther.</source> <volume>10</volume> (<issue>5</issue>), <fpage>112</fpage>&#x2013;<lpage>117</lpage>.</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2021a</year>). <article-title>Highly stable selenium nanoparticles: assembly and stabilization via flagellin FliC and porin OmpF in Rahnella aquatilis HX2</article-title>. <source>J. Hazard Mater</source> <volume>414</volume>, <fpage>125545</fpage>. <pub-id pub-id-type="doi">10.1016/j.jhazmat.2021.125545</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2021b</year>). <article-title>Curcumin protects radiation-induced liver damage in rats through the NF-&#x3ba;B signaling pathway</article-title>. <source>BMC Complement. Med. Ther.</source> <volume>21</volume> (<issue>1</issue>), <fpage>10</fpage>. <pub-id pub-id-type="doi">10.1186/s12906-020-03182-1</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Z. M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X. L.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>X. M.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J. Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L. S.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>The effect of selenium on antioxidant system in aquaculture animals</article-title>. <source>Front. Physiol.</source> <volume>14</volume>, <fpage>1153511</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2023.1153511</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Radioprotective countermeasures for radiation injury (Review)</article-title>. <source>Mol. Med. Rep.</source> <volume>27</volume>, <fpage>66</fpage>. <pub-id pub-id-type="doi">10.3892/mmr.2023.12953</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mamgain</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kostic</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>F. V.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Synthesis and antioxidant properties of organoselenium compounds</article-title>. <source>Curr. Med. Chem.</source> <volume>30</volume>, <fpage>2421</fpage>&#x2013;<lpage>2448</lpage>. <pub-id pub-id-type="doi">10.2174/0929867329666220801165849</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maynar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Llerena</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bartolom&#xe9;</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Alves</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Robles</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Grijota</surname>
<given-names>F. J.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Seric concentrations of copper, chromium, manganesum, nickel and selenium in aerobic, anaerobic and mixed professional sportsmen</article-title>. <source>J. Int. Soc. Sports Nutr.</source> <volume>15</volume>, <fpage>8</fpage>. <pub-id pub-id-type="doi">10.1186/s12970-018-0212-4</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Azfer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Kolattukudy</surname>
<given-names>P. E.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy</article-title>. <source>Cardiovasc Res.</source> <volume>73</volume> (<issue>3</issue>), <fpage>549</fpage>&#x2013;<lpage>559</lpage>. <pub-id pub-id-type="doi">10.1016/j.cardiores.2006.11.031</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ortega</surname>
<given-names>P. M.</given-names>
</name>
<name>
<surname>Magne</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Da</surname>
<given-names>S. N.</given-names>
</name>
<name>
<surname>Ramos Ribeiro</surname>
<given-names>E. R. F.</given-names>
</name>
<name>
<surname>Albuquerque Silva</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Ricci-Junior</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Ionizing radiation: chemical kinetics, chemical bounds, and radiation chemistry on polymers</article-title>. <source>Curr. Top. Med. Chem.</source> <volume>23</volume>, <fpage>1414</fpage>&#x2013;<lpage>1424</lpage>. <pub-id pub-id-type="doi">10.2174/1568026623666230315122855</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Development of nanotechnology-mediated precision radiotherapy for anti-metastasis and radioprotection</article-title>. <source>Chem. Soc. Rev.</source> <volume>51</volume>, <fpage>9759</fpage>&#x2013;<lpage>9830</lpage>. <pub-id pub-id-type="doi">10.1039/d1cs01145f</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pereira</surname>
<given-names>A. G.</given-names>
</name>
<name>
<surname>Gerolis</surname>
<given-names>L. G. L.</given-names>
</name>
<name>
<surname>Gon&#xe7;alves</surname>
<given-names>L. S.</given-names>
</name>
<name>
<surname>Moreira</surname>
<given-names>L. M. C.</given-names>
</name>
<name>
<surname>Gastelois</surname>
<given-names>P. L.</given-names>
</name>
<name>
<surname>Neves</surname>
<given-names>M. J.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Radiolytic synthesis and characterization of selenium nano particles: comparative biosafety evaluation with selenite and ionizing radiation</article-title>. <source>World J. Microbiol. Biotechnol.</source> <volume>38</volume> (<issue>2</issue>), <fpage>33</fpage>. <pub-id pub-id-type="doi">10.1007/s11274-021-03218-9</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ragini</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Arumugam</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>
<italic>In vivo</italic> studies on bioavailability, toxicity, and antioxidant defense of organic selenium-enriched microalga biomass in Wistar rats</article-title>. <source>J. Appl. Phycol.</source> <volume>35</volume>, <fpage>1699</fpage>&#x2013;<lpage>1713</lpage>. <pub-id pub-id-type="doi">10.1007/s10811-023-03007-x</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Traditional Chinese medicine active ingredients-based selenium nanoparticles regulate antioxidant selenoproteins for spinal cord injury treatment</article-title>. <source>J. Nanobiotechnology</source> <volume>20</volume>, <fpage>278</fpage>. <pub-id pub-id-type="doi">10.1186/s12951-022-01490-x</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruiz-Fresneda</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Staicu</surname>
<given-names>L. C.</given-names>
</name>
<name>
<surname>Lazuen-Lopez</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Merroun</surname>
<given-names>M. L.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Allotropy of selenium nanoparticles: colourful transition, synthesis, and biotechnological applications</article-title>. <source>Microb. Biotechnol.</source> <volume>16</volume>, <fpage>877</fpage>&#x2013;<lpage>892</lpage>. <pub-id pub-id-type="doi">10.1111/1751-7915.14209</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shimazu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kumta</surname>
<given-names>U. S.</given-names>
</name>
<name>
<surname>Tappel</surname>
<given-names>A. L.</given-names>
</name>
</person-group> (<year>1964</year>). <article-title>RADIATION DAMAGE TO METHIONINE AND ITS DERIVATIVES</article-title>. <source>Radiat. Res.</source> <volume>22</volume>, <fpage>276</fpage>&#x2013;<lpage>287</lpage>. <pub-id pub-id-type="doi">10.2307/3571659</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shirazi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Haddadi</surname>
<given-names>G. H.</given-names>
</name>
<name>
<surname>Asadi-Amoli</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Sakhaee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ghazi-Khansari</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Avand</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Radioprotective effect of melatonin in reducing oxidative stress in rat lenses</article-title>. <source>Cell. J.</source> <volume>13</volume> (<issue>2</issue>), <fpage>79</fpage>&#x2013;<lpage>82</lpage>.</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tarnuzzer</surname>
<given-names>R. W.</given-names>
</name>
<name>
<surname>Colon</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Patil</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Seal</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage</article-title>. <source>Nano Lett.</source> <volume>5</volume> (<issue>12</issue>), <fpage>2573</fpage>&#x2013;<lpage>2577</lpage>. <pub-id pub-id-type="doi">10.1021/nl052024f</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thakur</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ray</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Cisplatin triggers cancer stem cell enrichment in platinum-resistant cells through NF-&#x3ba;B-TNF&#x3b1;-PIK3CA loop</article-title>. <source>J. Exp. Clin. Cancer Res.</source> <volume>36</volume> (<issue>1</issue>), <fpage>164</fpage>. <pub-id pub-id-type="doi">10.1186/s13046-017-0636-8</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Selenium ameliorates Staphylococcus aureus-induced inflammation in bovine mammary epithelial cells by inhibiting activation of TLR2, NF-&#x3ba;B and MAPK signaling pathways</article-title>. <source>BMC Vet. Res.</source> <volume>14</volume> (<issue>1</issue>), <fpage>197</fpage>. <pub-id pub-id-type="doi">10.1186/s12917-018-1508-y</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Protective mechanism of a novel aminothiol compound on radiation-induced intestinal injury</article-title>. <source>Int. J. Radiat. Biol.</source> <volume>99</volume>, <fpage>259</fpage>&#x2013;<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1080/09553002.2022.2074163</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wijerathne</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Langston</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Miyamoto</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kilpatrick</surname>
<given-names>L. E.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Mechanisms of radiation-induced endothelium damage: emerging models and technologies</article-title>. <source>Radiother. Oncol.</source> <volume>158</volume>, <fpage>21</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.radonc.2021.02.007</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>B. K.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q. H.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sang</surname>
<given-names>L. X.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>A novel therapeutic strategy for hepatocellular carcinoma: immunomodulatory mechanisms of selenium and/or selenoproteins on a shift towards anti-cancer</article-title>. <source>Int. Immunopharmacol.</source> <volume>96</volume>, <fpage>107790</fpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2021.107790</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Development status on post-accident management strategy for nuclear and radiological accident</article-title>. <source>Radiat. Prot.</source> <volume>40</volume>, <fpage>177</fpage>&#x2013;<lpage>180</lpage>.</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zahran</surname>
<given-names>W. E.</given-names>
</name>
<name>
<surname>Elsonbaty</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Moawed</surname>
<given-names>F. S. M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Selenium nanoparticles with low-level ionizing radiation exposure ameliorate nicotine-induced inflammatory impairment in rat kidney</article-title>. <source>Environ. Sci. Pollut. Res. Int.</source> <volume>24</volume> (<issue>24</issue>), <fpage>19980</fpage>&#x2013;<lpage>19989</lpage>. <pub-id pub-id-type="doi">10.1007/s11356-017-9558-4</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>X. Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L. D.</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>Y. P.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Biological effects of a nano red elemental selenium</article-title>. <source>Biofactors</source> <volume>15</volume> (<issue>1</issue>), <fpage>27</fpage>&#x2013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1002/biof.5520150103</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>